StockWatch
·
Distributors
Board Meeting7 Sept 2026, 07:30 pm

Tavexia Lifecare Appoints New Auditor, Eyes Meyonex Acquisition

AI Summary

Tavexia Lifecare Ltd announced key board decisions including the resignation of its statutory auditor, M/s SSRV & Associates, and the appointment of M/s DEVAM & Associates LLP as the new statutory auditor for a five-year term, subject to member approval. The board also approved the re-appointment of Mrs. Khushboo Vasudev as an Independent Director for a second five-year term. Furthermore, the company is exploring the acquisition of up to 60% equity in Meyonex Pharmaceuticals Limited, authorizing directors to conduct due diligence and negotiations.

Key Highlights

  • New statutory auditor DEVAM & Associates LLP appointed.
  • Mrs. Khushboo Vasudev re-appointed as Independent Director.
  • Company exploring acquisition of up to 60% in Meyonex Pharmaceuticals.
  • Board authorized directors for acquisition due diligence and negotiations.